Top Story

Top 5 online stories posted in January

February 12, 2016

Endocrine Today compiled a list of the top five news reports posted in January.

Healio.com/Endocrinology readers were interested in changes in fat distribution and their effects on insulin sensitivity, the link between heart failure and DPP-IV inhibitors, hyperbaric oxygen therapy for would healing, and much more.

CMS extends 2015 EHR meaningful use attestation deadline

February 12, 2016
CMS has extended the deadline to attest to meaningful use of electronic health records for 2015, according to an email from the agency.Providers in the Medicare &…
In the Journals

High normal range atrial natriuretic peptide may reduce insulin resistance risk in middle age

February 12, 2016
Exposure during middle age to atrial natriuretic peptide within the high normal range appears to be associated with a reduced risk for insulin resistance after 16.5…

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…
In the Journals

Obesity hypoventilation syndrome often misdiagnosed, affecting mortality

February 12, 2016
Many patients with obesity hypoventilation syndrome are misdiagnosed as having other respiratory conditions and receive inappropriate therapy, likely contributing to a…
More News Headlines »

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Meeting News CoverageVideo

VIDEO: Positive CV outcomes with SGLT2 inhibitors mark ‘an exciting time’

Cardiology Today, February 2016
More »

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Current Issues
View the Current Issues
morganatic-roan morganatic-roan